Auxilium Pharmaceuticals and FCB I File Lawsuit Against Watson for Infringement of Testim Patents
Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL) and FCB I LLC announced today that they filed a lawsuit against Watson Laboratories, Inc. (NV); Watson Pharmaceuticals, Inc. (NYSE: WPI); and Watson Pharma, Inc. for infringement of FCB's ten patents listed in the U.S. Food and Drug Administration's Approved Drug Products with Therapeutic Equivalence Evaluations as covering Testim® 1% testosterone gel.
The lawsuit was filed in the United States District Court for the District of New Jersey on May 23, 2012.
© 2017 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.